Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Brain scans and imaging

Topic: Brain imaging, connectivity and assessment

RNT was associated with increasing global amyloid accumulation even after controlling for psychological symptoms (B = 0.0120, 95% Confidence Interval 0.003 to 0.021, P = 0.012), and in sensitivity analyses limited to participants aged ≥50 or ≥60. Post-hoc tests showed a significant difference in rate of amyloid accumulation between the lowest and highest RNT tertiles (P=0.008). Voxelwise analyses revealed that RNT predicted significantly faster increases in regions vulnerable to early amyloid accumulation in AD (e.g. precuneus, posterior cingulate cortex, and medial frontal cortex). RNT was not associated with change in glucose metabolism or brain atrophy (Ps>0.05). Neither anxiety nor depressive symptoms were associated with change in any neuroimaging outcome (Ps>0.05). Conclusions and Relevance: Higher RNT was associated with more rapid accumulation of cortical amyloid in regions affected early in AD. These findings indicate that this transdiagnostic cognitive-emotional process may be an early marker and/or driver of AD pathology. Given that RNT is responsive to treatment, future research is needed to investigate whether modifying RNT reduces AD risk.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 22 of the 62 points it could be judged on, which is 35 of 100. Raw total 35 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 35 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 35 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 22 of the 62 points we could judge it on, which is 35 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 22 / 62 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 22 of the 62 points we could judge it on is 35 out of 100.
Total 35 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Marchant, N. L., Mezenge, F., Raghavan, A. V., Saul, E., De La Sayette, V., The IMAP Research Group, et al. (2026). Repetitive negative thinking is associated with amyloid accumulation over 3 years in cognitively healthy adults. medRxiv. https://doi.org/10.64898/2026.10.29.26366526

Vancouver

Marchant NL, Mezenge F, Raghavan AV, Saul E, De La Sayette V, The IMAP Research Group, et al. Repetitive negative thinking is associated with amyloid accumulation over 3 years in cognitively healthy adults. medRxiv. 2026. doi:10.64898/2026.10.29.26366526.

BibTeX

@article{marchant2026-7e465f34,
  author  = {Marchant, N. L. and Mezenge, F. and Raghavan, A. V. and Saul, E. and De La Sayette, V. and {The IMAP Research Group} and Chételat, G.},
  title   = {{Repetitive negative thinking is associated with amyloid accumulation over 3 years in cognitively healthy adults}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.10.29.26366526},
  url     = {https://doi.org/10.64898/2026.10.29.26366526}
}

Related studies in Brain scans and imaging

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →